Global epidemiology and burden of hepatitis C.

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet (2009) 14.16

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature (2010) 8.95

Characterization of a canine homolog of hepatitis C virus. Proc Natl Acad Sci U S A (2011) 2.14

Patterns of drug use among a sample of drug users and injecting drug users attending a General Practice in Iran. Harm Reduct J (2006) 1.97

Bats are a major natural reservoir for hepaciviruses and pegiviruses. Proc Natl Acad Sci U S A (2013) 1.93

Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med (2014) 1.66

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health (2009) 1.62

Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene. Gut (2012) 1.52

Investigating the origin and spread of hepatitis C virus genotype 5a. J Virol (2006) 1.16

Single nucleotide polymorphisms of the IL28B and sustained virologic response of patients with chronic hepatitis C to PEG-interferon/ribavirin therapy: A meta-analysis: Meta-analysis of IL28B. Hepat Mon (2011) 1.06

Management of chronic hepatitis C. Postgrad Med J (2005) 1.03

Prevalence of active hepatitis c virus infection in district Mansehra Pakistan. Virol J (2010) 1.02

Prevalence of active hepatitis C virus infections among general public of Lahore, Pakistan. Virol J (2013) 0.94

Prediction of response to pegylated-interferon-α and ribavirin therapy in Chinese patients infected with different hepatitis C virus genotype. Virol J (2012) 0.90

Vertical transmission of hepatitis C virus: Current knowledge and perspectives. World J Hepatol (2014) 0.89

Initiation to heroin injecting among heroin users in Sydney, Australia: cross sectional survey. Harm Reduct J (2005) 0.88

Effect of interferon treatment on hearing of patients with chronic hepatitis C. Saudi J Gastroenterol (2011) 0.86

Growth differentiation factor 15 is induced by hepatitis C virus infection and regulates hepatocellular carcinoma-related genes. PLoS One (2011) 0.83

Increased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT/enhancer-binding protein β. J Biol Chem (2012) 0.82

Simultaneous genotyping of rs12979860 and rs8099917 variants near the IL28B locus associated with HCV clearance and treatment response. J Mol Diagn (2011) 0.82

Anti-HCV reactive volunteer blood donors distribution character and genotypes switch in Xi'an, China. Virol J (2010) 0.82

Dynamics of resistance mutations to NS3 protease inhibitors in a cohort of Brazilian patients chronically infected with hepatitis C virus (genotype 1) treated with pegylated interferon and ribavirin: a prospective longitudinal study. Virol J (2013) 0.82

Reproduction in vitro of a quasispecies from a hepatitis C virus-infected patient and determination of factors that influence selection of a dominant species. J Virol (2011) 0.80

Taking account of future technology in cost effectiveness analysis. BMJ (2004) 0.80

Significance of monoclonal antibodies against the conserved epitopes within non-structural protein 3 helicase of hepatitis C virus. PLoS One (2013) 0.79

Interleukin-28B (rs12979860) gene variation and treatment outcome after peginterferon plus ribavirin therapy in patients with genotype 1 of hepatitis C virus. J Res Med Sci (2014) 0.79

Injecting Drug Users Retention in Needle-Exchange Program and its Determinants in Iran Prisons. Int J High Risk Behav Addict (2015) 0.79

A thymine-adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virus. J Gastroenterol (2015) 0.78

The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia. BMC Public Health (2005) 0.77

Impact of host responses on control of hepatitis C virus infection in Chinese blood donors. Biochem Biophys Res Commun (2011) 0.77

Factors associated with spontaneous clearance of hepatitis C virus in Chinese population. Biomed Res Int (2014) 0.77

Hypothesis: Targeted Ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes. Hepat Med (2010) 0.77

Microsomal Epoxide Hydrolase Polymorphisms and Haplotypes as Determinants of Hepatitis B Virusand Hepatitis C Virus-related Liver Disease in Indian Population. J Clin Exp Hepatol (2012) 0.77

To study the prevalence of impaired glucose tolerance in patients with hepatitis C virus related chronic liver disease. J Clin Diagn Res (2015) 0.77

Hepatitis C and blood transfusion among children attending the Sickle Cell Clinic at Mulago Hospital, Uganda. Afr Health Sci (2013) 0.76

Potent Hepatitis C Virus NS5A Inhibitors Containing a Benzidine Core. ACS Med Chem Lett (2013) 0.76

Cost comparison of treating chronic hepatitis C genotype one with pegylated interferons in Ukraine. Open Med (Wars) (2014) 0.75

Using decision tree learning to predict the responsiveness of hepatitis C patients to drug treatment. FEBS Open Bio (2012) 0.75